{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:05:03Z","timestamp":1648609503998},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Seracare LLC"},{"name":"LGC Clinical Diagnostics Division","award":["WO2018094183A1"],"award-info":[{"award-number":["WO2018094183A1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Highly characterized reference materials are required to expand noninvasive prenatal testing (NIPT) for low incidence aneuploidies and microdeletions. The goal of this study was to develop reference materials for the development of next generation circulating cell-free DNA (ccfDNA) assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a prospective study of pregnancies complicated by positive prenatal genetic screening. ccfDNA was isolated from maternal plasma and amplified. Lymphoblastoid cell lines were prepared from maternal peripheral blood mononuclear cells and fetal cord blood cells. Cells were Epstein-Barr virus immortalized and expanded. Amplified DNA and to a limited extent formulated lymphoblastoid-derived ccfDNA was tested in SNP-based and chromosome counting (CC) based massively parallel sequencing assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Enrolled cases included fetuses with: T21 (2), T18 (1), T18-XXX (1), XYY (1), microdeletions (1), and euploid (2). Three lymphoblastoid cells lines were prepared. Genomic DNA was extracted from cell lines and fragmented to simulate ccfDNA. ccfDNA isolation yielded about 2000 usable genome equivalents of DNA for each case for amplification. Although the sonicated genomic DNA derived from lymphoblastoid cell lines did not yield results compatible with NIPT assays, when blinded, NIPT platforms correctly identified the amplified ccfDNA isolated from blood in the majority of cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study showed that maternal blood samples from pregnancies complicated by common chromosomal abnormalities can be used to generate materials for the development and evaluation of NIPT assays.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jalm\/jfab037","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T03:15:56Z","timestamp":1617851756000},"page":"1492-1504","source":"Crossref","is-referenced-by-count":0,"title":["Novel Approaches to Develop Critical Reference Materials for Noninvasive Prenatal Testing: A Pilot Study"],"prefix":"10.1093","volume":"6","author":[{"given":"Katherine","family":"Bianco","sequence":"first","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth B","family":"Sherwin","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Konigshofer","sequence":"additional","affiliation":[{"name":"LGC Clinical Diagnostics Division, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna I","family":"Girsen","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl G","family":"Sylvester","sequence":"additional","affiliation":[{"name":"Division of Pediatric Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell K","family":"Garlick","sequence":"additional","affiliation":[{"name":"LGC Clinical Diagnostics Division, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"2021110213160708100_jfab037-B1","year":"2017"},{"key":"2021110213160708100_jfab037-B2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pd.4125","article-title":"Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening","volume":"33","author":"Chetty","year":"2013","journal-title":"Prenat Diagn"},{"key":"2021110213160708100_jfab037-B3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pd.4659","article-title":"The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"key":"2021110213160708100_jfab037-B4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/pd.1647","article-title":"Age-specific risk of fetal loss post second trimester amniocentesis: Analysis of 5043 cases","volume":"27","author":"Mazza","year":"2007","journal-title":"Prenat Diagn"},{"key":"2021110213160708100_jfab037-B5","doi-asserted-by":"publisher","first-page":"CD003252","DOI":"10.1002\/14651858.CD003252","article-title":"Amniocentesis and chorionic villus sampling for prenatal diagnosis","volume":"9","author":"Alfirevic","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2021110213160708100_jfab037-B6","doi-asserted-by":"crossref","first-page":"e0132313","DOI":"10.1371\/journal.pone.0132313","article-title":"An economic analysis of cell-free DNA non-invasive prenatal testing in the US general pregnancy population","volume":"10","author":"Benn","year":"2015","journal-title":"PLoS One"},{"key":"2021110213160708100_jfab037-B7","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41436-019-0485-2","article-title":"Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations","volume":"21","author":"Skotko","year":"2019","journal-title":"Genet Med"},{"key":"2021110213160708100_jfab037-B8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/AOG.0000000000000637","article-title":"Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology","volume":"125","author":"Bianchi","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B10","first-page":"e123\u201337","article-title":"163: Screening for fetal aneuploidy","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: A position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"key":"2021110213160708100_jfab037-B12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1311037","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","volume":"370","author":"Bianchi","year":"2014","journal-title":"N Engl J Med"},{"key":"2021110213160708100_jfab037-B13","doi-asserted-by":"crossref","first-page":"374.e1","DOI":"10.1016\/j.ajog.2012.08.033","article-title":"Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population","volume":"207","author":"Nicolaides","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B14","year":"2020"},{"key":"2021110213160708100_jfab037-B15","doi-asserted-by":"crossref","first-page":"626.e1","DOI":"10.1016\/j.ajog.2016.06.039","article-title":"Cell-free DNA screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results","volume":"215","author":"Valderramos","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B16","doi-asserted-by":"crossref","first-page":"332.e1","DOI":"10.1016\/j.ajog.2014.11.041","article-title":"Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes","volume":"212","author":"Wapner","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/522029a","article-title":"Pregnancy: prepare for unexpected prenatal test results","volume":"522","author":"Bianchi","year":"2015","journal-title":"Nature"},{"key":"2021110213160708100_jfab037-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0193476","article-title":"Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples","volume":"13","author":"Ravi","year":"2018","journal-title":"PLoS One"},{"key":"2021110213160708100_jfab037-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13039-019-0459-8","article-title":"Targeted capture enrichment followed by NGS: development and validation of a single comprehensive NIPT for chromosomal aneuploidies, microdeletion syndromes and monogenic diseases","volume":"12","author":"Koumbaris","year":"2019","journal-title":"Mol Cytogenet"},{"key":"2021110213160708100_jfab037-B20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/pd.5438","article-title":"Ensuring high standards for the delivery of NIPT world-wide: development of an international external quality assessment scheme","volume":"39","author":"Deans","year":"2019","journal-title":"Prenat Diagn"},{"key":"2021110213160708100_jfab037-B21"},{"key":"2021110213160708100_jfab037-B22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/BF02619631","article-title":"Use of cyclosporin a in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines","volume":"20","author":"Anderson","year":"1984","journal-title":"In Vitro"},{"key":"2021110213160708100_jfab037-B23","first-page":"8.15.1","article-title":"Noninvasive prenatal testing using cell-free fetal DNA in maternal plasma","volume":"2015","author":"Dharajiya","year":"2015","journal-title":"Curr Protoc Hum Genet"},{"key":"2021110213160708100_jfab037-B24","author":"Konigshofer","year":"2018"},{"key":"2021110213160708100_jfab037-B25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2021110213160708100_jfab037-B26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/pd.4862","article-title":"Placental transcriptomes in the common aneuploidies reveal critical regions on the trisomic chromosomes and genome-wide effects","volume":"36","author":"Bianco","year":"2016","journal-title":"Prenat Diagn"},{"key":"2021110213160708100_jfab037-B27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/uog.13277","article-title":"Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center","volume":"43","author":"Lau","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B28","doi-asserted-by":"crossref","first-page":"691.e1","DOI":"10.1016\/j.ajog.2017.10.005","article-title":"Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory","volume":"217","author":"Petersen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2021110213160708100_jfab037-B29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1373\/clinchem.2018.299602","article-title":"Generation of highly biomimetic quality control materials for noninvasive prenatal testing based on enzymatic digestion of matched mother-child cell lines","volume":"65","author":"Zhang","year":"2019","journal-title":"Clin Chem"},{"key":"2021110213160708100_jfab037-B30","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/ejhg.2015.57","article-title":"Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening","volume":"23","author":"Dondorp","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"2021110213160708100_jfab037-B31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size distributions of maternal and fetal DNA in maternal plasma","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"key":"2021110213160708100_jfab037-B32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1373\/clinchem.2010.144188","article-title":"Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing","volume":"56","author":"Fan","year":"2010","journal-title":"Clin Chem"},{"key":"2021110213160708100_jfab037-B33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pd.4615","article-title":"Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts","volume":"35","author":"Kim","year":"2015","journal-title":"Prenat Diagn"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/6\/1492\/41046974\/jfab037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/6\/1492\/41046974\/jfab037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T13:40:30Z","timestamp":1635860430000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/6\/6\/1492\/6291626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,3]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfab037","relation":{},"ISSN":["2576-9456","2475-7241"],"issn-type":[{"value":"2576-9456","type":"print"},{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,6,3]]}}}